English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1440]
News [2204]
Articles [39]
Editorials [5]
Conferences [149]
elearning [0]
Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed
Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed
Large differences in cancer survival between European countries still remain despite major improvements in cancer diagnosis and treatment
Large differences in cancer survival between European countries still remain despite major improvements in cancer...
ERA-NET on Translational Cancer Research: Call for Proposals
ERA-NET on Translational Cancer Research: Call for Proposals
FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels
FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels
Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’
Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’
Scientists break blood-brain barrier to allow cancer drugs in
Scientists break blood-brain barrier to allow cancer drugs in
Patient advocate groups protest anachronistic Dutch Medicines Act at 2013 European Cancer Congress
Patient advocate groups protest anachronistic Dutch Medicines Act at 2013 European Cancer Congress
Phase III START2 trial for tecemotide in stage III non-small cell lung cancer
Phase III START2 trial for tecemotide in stage III non-small cell lung cancer
Melanoma white paper: Reshaping EU healthcare for melanoma patients
Melanoma white paper: Reshaping EU healthcare for melanoma patients
Ponatinib gains marketing authorization in the European Union
Ponatinib gains marketing authorization in the European Union
<1...214215216217218...221>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top